(Senior) Medical Science Liaison - East New England

Massachusetts, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates must possess an advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN) and a fundamental understanding of molecular oncology, comprehensive genomic profiling, tumor evolution, and targeted therapy options. Existing Key Opinion Leader (KOL) relationships in oncology are required, along with working knowledge of genomic laboratory-developed testing (LDT) with tissue and liquid biopsy, and familiarity with CLIA-88’, CAP, and Sunshine Act (2013). Proficient public speaking, exceptional interpersonal communication, and strong inter/intradepartmental management skills are necessary. The role requires a self-starter capable of autonomous work and delivering under tight timelines, with the ability to travel up to 50%. Preferred qualifications include 1+ years of MSL experience in diagnostics, biotech, or pharmaceutical industries. Candidates residing in CT/RI/MA are preferred.

Responsibilities

The Medical Science Liaison (MSL/Sr. MSL) will support Tempus's objectives by educating physicians, particularly oncologists, pathologists, and advanced practice providers, on Tempus assays and technologies. This includes providing clinical science support for physician inquiries regarding patient NGS test results and scientific data review. The role involves supporting commercial team efforts by exchanging clinical, scientific, and technical information with regional KOLs and other healthcare providers, delivering educational presentations, and facilitating speaker engagements. Additionally, the MSL will support virtual tumor board presentations, provide scientific education for internal stakeholders, attend conferences to facilitate KOL meetings and summarize key findings, and continuously update internal teams on relevant medical insights.

Skills

Oncology

Genomic Testing

NGS

ctDNA

Medical Science Liaison

Clinical Research

Presentation Skills

Communication Skills

KOL Engagement

Precision Medicine

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free